Advertisement

Making a Shared Decision on Meningococcal B Vaccine: Provider Feedback on an Educational Tool Developed for Use With Patients

Published:January 22, 2022DOI:https://doi.org/10.1016/j.acap.2022.01.006

      Abstract

      Background

      In 2015, the Advisory Committee on Immunization Practices recommended Meningococcal B vaccination for healthy 16- to 23-year-olds based on shared clinical decision-making between the patient and the provider. There has been some confusion regarding how to implement this recommendation.

      Methods

      Through discussions among the authors, a review of relevant literature, and consultation with vaccine experts, we developed educational materials for providers that included a patient handout to help initiate and guide conversations leading to shared clinical decision-making for the Meningococcal B vaccine. Materials were distributed to 88 health care providers who subsequently completed surveys to evaluate their impressions of the materials and the utility of the materials for clinical practice.

      Results

      The survey results from the 88 providers revealed that they valued the materials; 93% percent indicated they would share these materials with colleagues, and 95% agreed or strongly agreed that they would share these materials with patient families. Responses to an open-ended question indicate that some providers initiated discussions regarding the Meningococcal B vaccine in ways that truncated conversation rather than encouraging a shared decision-making process.

      Conclusions

      Overall, the materials developed and implemented for this project support the initiation of, and help standardize provider conversations regarding, Meningococcal B vaccination for healthy adolescents.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Academic Pediatrics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Mbaeyi SA
        • Bozio CH
        • Duffy J
        • et al.
        Meningococcal vaccination: recommendations of the Advisory Committee on Immunization Practices, United States, 2020.
        MMWR Recomm Rep. 2020; 69: 1-41
        • Purmohamad A
        • Abasi E
        • Azimi T
        • et al.
        Global estimate of Neisseria meningitidis serogroups proportion in invasive meningococcal disease: a systematic review and meta-analysis.
        Microb Pathog. 2019; 134103571
        • CDC
        Enhanced Meningococcal Disease Surveillance Reports, 2015.
        US Department of Health and Human Services, CDC, Atlanta, Ga2017 (Available at:)
        • Folaranmi T
        • Rubin L
        • Martin SW
        • et al.
        Use of serogroup B meningococcal vaccines in persons aged ≥10 years at increased risk for serogroup B meningococcal disease: recommendations of the Advisory Committee on Immunization Practices, 2015.
        MMWR Morb Mortal Wkly Rep. 2015; 64: 608-612
        • MacNeil JR
        • Rubin L
        • Folaranmi T
        • et al.
        Use of serogroup B meningococcal vaccines in adolescents and young adults: recommendations of the Advisory Committee on Immunization Practices, 2015.
        MMWR. 2015; 64: 1171-1176
      1. Advisory Committee on Immunization Practices. Summary Report, June 26-27, 2019. Available at: https://www.cdc.gov/vaccines/acip/meetings/downloads/min-archive/min-2019-06-508.pdf. Accessed July 24, 2021.

        • Meites E
        • Szilagyi PG
        • Chesson HW
        • et al.
        Human papillomavirus vaccination for adults: updated recommendations of the Advisory Committee on Immunization Practices.
        MMWR Morb Mortal Wkly Rep. 2019; 68: 698-702
        • Matanock A
        • Lee G
        • Gierke R
        • et al.
        Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged >/=65 years: updated recommendations of the Advisory Committee on Immunization Practices.
        MMWR Morb Mortal Wkly Rep. 2019; 68: 1069-1075
        • Huang L
        • Goren A
        • Lee LK
        • et al.
        Disparities in healthcare providers’ interpretations and implementations of ACIP’s meningococcalvaccine recommendations.
        Hum Vaccin Immunother. 2020; 16: 933-944
        • Kempe A
        • Allison MA
        • MacNeil JR
        • et al.
        Knowledge and attitudes regarding category B ACIP recommendations among primary care providers for children.
        Acad Pediatr. 2018; 18: 763-768
        • Kempe A
        • Allison MA
        • MacNeil JR
        • et al.
        Adoption of serogroup B meningococcal vaccine recommendations.
        Pediatrics. 2018; 142https://doi.org/10.1542/peds.2018-0344
        • Elam-Evans LD
        • Yankey D
        • Singleton JA
        • et al.
        National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years — United States, 2019.
        MMWR Morb Mortal Wkly Rep. 2020; 69: 1109-1116https://doi.org/10.15585/mmwr.mm6933a1
        • Marshall GS
        • Tan LJ.
        Understanding the category B recommendation for serogroup B meningococcal vaccine.
        Pediatrics. 2017; 139e20163484https://doi.org/10.1542/peds.2016-3484
      2. Available at: https://www.cdc.gov/vaccines/acip/acip-scdm-faqs.html. Accessed August 10, 2021.

        • Srivastava A
        • Alderfer J.
        279. Improving meningococcal B vaccination among US college students.
        J Adolesc Health. 2020; 66: S141https://doi.org/10.1016/j.jadohealth.2019.11.282
      3. Available at: http://www.icmje.org/recommendations/. Accessed September 30, 2021.

        • Opel DJ
        • Heritage J
        • Taylor JA
        • et al.
        The architecture of provider-parent vaccine discussions at health supervision visits.
        Pediatrics. 2013; 132: 1037-1046https://doi.org/10.1542/peds.2013-2037
        • Clark S
        • Freed G
        • Singer D
        • et al.
        Parents not Keeping up With Teen Vaccines.
        C.S. Mott Children’s Hospital National Poll on Children’s Health, University of Michigan, Michigan2017: 29 (Available at:)
        • Beach MC
        • Sugarman J
        Realizing shared decision-making in practice.
        JAMA. 2019; https://doi.org/10.1001/jama.2019.9797
        • Elwyn G
        • Frosch D
        • Thomson R
        • et al.
        Shared decision making: a model for clinical practice.
        J Gen Intern Med. 2012; 27: 1361-1367
      4. Agency for Healthcare Research and Quality. The SHARE approach. Essential steps of shared decision-making: expanded reference guide with sample conversation starters. Available at:https://www.ahrq.gov/sites/default/files/wysiwyg/professionals/education/curriculum-tools/shareddecisionmaking/tools/tool-2/share-tool2.pdf. Accessed March 3, 2020.

      5. Lee GM. Shared Clinical Decision–Making For Immunization Recommendations. 2020. Available at:https://www.gotostage.com/channel/ff5edf4ebb134ec481037f5c774daa3f/recording/62c4059dfe71461fadfd80cb3d5be82a/watch. Accessed February 19, 2020.

        • Brady M.
        Strength and clarity of vaccine recommendations influence providers’ practice.
        Pediatrics. 2018; 142e20181633
        • Niccolai LM
        • Hansen CE.
        Suboptimal uptake of meningococcal vaccines among older adolescents: barriers, solutions, and future research directions.
        Hum Vaccin Immunother. 2020; 16: 3208-3212
        • Basta NE
        • Becker AB
        • Qingxiao L
        • et al.
        Parental awareness of meningococcal B vaccines and willingness to vaccinate their teens.
        Vaccine. 2019; 37: 670-676
        • Marshall GS
        • Dempsey AF
        • Srivasta A
        • et al.
        US College Students are at increased risk for Serogroup B meningococcal disease.
        J Pediatr Infect Dis Society. 2020; 9: 244-247
        • Srivastava A
        • Dempsey A
        • Galitsky A
        • et al.
        Parental awareness and utilization of meningococcal serogroup B vaccines in the United States.
        BMC Public Health. 2020; 20: 1109
        • Fergie J
        • Howard A
        • Huang L
        • et al.
        Implementation experience with meningococcal serogroup B vaccines in the United States.
        Pediatr Infect Dis J. 2021; 40: 269-275
        • Brewer NT
        • Hall ME
        • Malo TL
        • et al.
        Announcements versus conversations to improve HPV vaccination coverage: a randomized trial.
        Pediatrics. 2017; 139e20161764
        • Hansen CE
        • Niccolai LM.
        Factors associated with receipt of meningococcal B vaccine among United States adolescents, National Immunization Survey-Teen, 2017-2018.
        J Adolesc Health. 2021; https://doi.org/10.1016/j.jadohealth.2021.04.029
        • La EM
        • Garbinsky D
        • Hunter S
        • et al.
        Meningococcal B vaccination coverage among older adolescents in the United States.
        Vaccine. 2021; 39: 2660-2667
        • Bruel S
        • Leclercq
        • Ginzarly M
        • et al.
        Patient decision aid in vaccination: a systematic review of the literature.
        Expert Rev Vaccin. 2020; 19: 305-311